Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)
暂无分享,去创建一个
D. Gerding | G. Rahav | M. Wilcox | Christine H. Lee | C. Kelly | N. Kartsonis | O. Cornely | M. Dorr | A. Pedley | D. Guris | Richard Nathan | I. Poxton | R. Tipping | K. Eves | Alison Pedley